Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients
- 1 December 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (8) , 4110-4112
- https://doi.org/10.1016/s0041-1345(98)01361-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graftClinical Transplantation, 1996
- GanciclovirNew England Journal of Medicine, 1996
- CYTOMEGALOVIRUS AS A CAUSE OF MORBIDITY IN HEART TRANSPLANTATIONTransplantation, 1996
- Opportunistic infections in the cardiac transplant patientCurrent Opinion in Cardiology, 1996
- PROPHYLACTIC GANCICLOVIR TREATMENT REDUCES FUNGAL AS WELL AS CYTOMEGALOVIRUS INFECTIONS AFTER HEART TRANSPLANTATION1,2Transplantation, 1995
- A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart TransplantationNew England Journal of Medicine, 1992
- Cytomegalovirus infections in heart and heart-lung transplant recipientsJournal of Antimicrobial Chemotherapy, 1989